Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

What Is The Role Of The Spleen In Anxiety And Stress?

XTALKS VITALS NEWS

Anxiety

The findings suggest that an excess of white blood cells in the spleen may be sending behavior-altering messages to brain for a long period of time after mice experience stress.

Share this!

November 23, 2016 | by Sarah Hand, M.Sc.

New research is helping to elucidate the relationship between the brain and the immune system in people experiencing prolonged anxiety after stress. The findings suggest that an excess of white blood cells in the spleen may be sending behavior-altering messages to brain for a long period of time after mice experience stress.

“We found that immune cells in the spleen can contribute to chronic anxiety following psychological stress,” said lead study author Daniel McKim, a graduate student at Ohio State University. “Our findings emphasize the possibility that the immune system represents a novel therapeutic target for the treatment of mental health conditions.”



McKim and his colleagues are focused on explaining the role between immunity and stress in mice who have faced “repeated social defeat,” in an effort to one-day improve the lives of people who suffer the effects of chronic psychological stress. The research was recently presented at Neuroscience 2016, the annual meeting of the Society for Neuroscience.

“Stress appears to prompt the release of stem cells from the bone marrow to the spleen, where they develop into white blood cells, or monocytes, and expand over time,” said co-author Jonathan Godbout. “Then the spleen becomes a reservoir of inflammatory cells.”

The researchers found that immune cell changes were consistent for nearly a month after the mice had experienced stress. They said that the spleen has been recognized as an important player in the sensitization that occurs in mice who have experienced prolonged stress, leading to both anxiety and cognitive problems later on in life.

Previous work conducted by the lab at Ohio State University, has shown that mice exposed to chronic stress face an increased risk of long-term anxiety and depression. This mouse model has been compared to the same symptoms seen in people with post-traumatic stress disorder.

“Maybe anxiety is a good thing for survival - it’s beneficial evolutionarily - but the issue becomes what happens when that system is put into overdrive,” said Godbout. “That’s when it gets problematic.”


Keywords: Immune System, Anxiety, Stress


| NEXT ARTICLE | MORE NEWS | BLOGS | VIDEOS | POLLS & QUIZZES | WEBINARS |

Share this with your colleagues!

MORE NEWS
Use of Testosterone Treatments Boosted by DTC Ad Campaigns

March 24, 2017 - Those with a stake in the pharmaceutical industry often question the effectiveness of direct-to-consumer (DTC) advertising, and whether it truly influences consumers to talk to their doctors about medical conditions and perhaps even ask for drugs by name.

Featured In: Pharmaceutical Marketing News


FDA Approves New Drug for Parkinson’s Disease

March 23, 2017 - Newron Pharmaceuticals’ Xadago (safinamide) has been approved by the US Food and Drug Administration (FDA) as an add-on medication for patients with Parkinson’s disease.

Featured In: Clinical Trials News, Life Science News, Pharmaceutical News


Amgen Identifies Issue with Patient Access to PCSK9 Inhibitor

March 23, 2017 - Most US patients hoping to get their PCSK9 inhibitor medications covered by their prescription drug plan are being denied, according to two new studied conducted by Amgen.

Featured In: Biotech News

LEAVE A COMMENT
 
  
THE XTALKS VITALS LIFE SCIENCE BLOG

Will Pharmaceutical Serialization Solve All of Our Drug Counterfeiting Problems?

REGISTER FOR THESE WEBINARS

How to Improve the Speed and Efficiency of Your Clinical Trials


High Performance Computing for High Content Screening - A Case Study


The FDA Guidance on the Assessment of Abuse Potential of Drug – A Critical Review


Treatment of Psoriasis: Improvements Through Clinical Trials


Copyright © 2016-2017 Honeycomb Worldwide Inc.